Shan Xing

Director, US Medical New Product Planning
Takeda Development Center Americas, Inc., Cambridge, MA

Presentation(s):

• PB0688 - Effect of PK Assessment on clinical outcomes for patients with moderate to severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0689 - Effects of PK Assessment on FVIII Consumption and Estimated Costs for patients with moderate to severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM